DrugPatentWatch Database Preview
Drugs in Development Information for Telotristat ethyl
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the drug development status for Telotristat ethyl?
Telotristat ethyl is an investigational drug.
There have been 11 clinical trials for Telotristat ethyl.
The most recent clinical trial was a Phase 1 trial, which was initiated on April 1st 2020.
The most common disease conditions in clinical trials are Malignant Carcinoid Syndrome, Serotonin Syndrome, and Neuroendocrine Tumors. The leading clinical trial sponsors are Lexicon Pharmaceuticals, Ipsen, and National Cancer Institute (NCI).
There are twelve US patents protecting this investigational drug and one hundred and nine international patents.
Summary for Telotristat ethyl
| US Patents | 12 |
| International Patents | 109 |
| US Patent Applications | 28 |
| WIPO Patent Applications | 21 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 1 (2020-04-01) |
| Vendors | 33 |
Recent Clinical Trials for Telotristat ethyl
| Title | Sponsor | Phase |
|---|---|---|
| Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer | Lexicon Pharmaceuticals | Phase 2 |
| Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer | Emory University | Phase 2 |
| Lanreotide Combined With Telotristat Ethyl or Placebo for the First-line Treatment in Patients With Advanced Well Differentiated Small Intestinal Neuroendocrine Tumours (siNET) With Highly-functioning Carcinoid Syndrome | Ipsen | Phase 3 |
Clinical Trial Summary for Telotristat ethyl
Top disease conditions for Telotristat ethyl
Top clinical trial sponsors for Telotristat ethyl
US Patents for Telotristat ethyl
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Telotristat ethyl | Start Trial | Tricyclic imidazole compounds as inhibitors of tryptophan hydroxylase | ACTELION PHARMACEUTICALS LTD (Allschwil, CH) | Start Trial |
| Telotristat ethyl | Start Trial | 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use | Lexicon Pharmaceuticals, Inc. (The Woodlands, TX) | Start Trial |
| Telotristat ethyl | Start Trial | 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use | Lexicon Pharmaceuticals, Inc. (The Woodlands, TX) | Start Trial |
| Telotristat ethyl | Start Trial | Methods of using 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds | Lexicon Pharmaceuticals, Inc. (The Woodlands, TX) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Telotristat ethyl
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Telotristat ethyl | Canada | 2927121 | 2033-11-19 | Start Trial |
| Telotristat ethyl | China | 105745211 | 2033-11-19 | Start Trial |
| Telotristat ethyl | European Patent Office | 3071567 | 2033-11-19 | Start Trial |
| Telotristat ethyl | Spain | 2650921 | 2033-11-19 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
